Drinker Biddle & Reath has been retained as corporate and securities counsel to CannaPharmaRx, an early-stage pharmaceutical firm focused on advancing research and discovery in the cannabinoid industry, according to a press release issued by the company on April 21, missing by one day a key date in marijuana history.
Doug Raymond, a Drinker Biddle corporate partner in Philadelphia and board member for local economic development nonprofit Aeris Insight, was not available for comment about his work for Carneys Point, New Jersey-based CannaPharmaRx.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
